Health Care · Services-Health Services · Nasdaq · CIK 1845257 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $10.74Day −1.10%Mkt cap $4.4B1Y +153.9%Off 52W high −8.7%Vol (1Y) 58.1%
Daily closing price, split-adjusted to the current basis; 3y shown of 944 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Price impliesNEVER-OBSERVED · 75.1% growth |
| Short interest2.4% of sh out |
| Days to cover2.7d |
| 13F net flow (QoQ)−2.13% |
| Top-10 13F concentration80.4% |
| Next report (est.)2026-08-06 |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$1.49B |
| Earnings (TTM)$23.2M |
| ROE0.7% |
| Net margin0.7% |
| ROIC1.2% |
| Debt / equity0.18× |
| YTD+52.6% |
| 1Y+153.9% |
| 3Y+14.4% |
| Since incept. (ann.)+1.2% |
Total return through 2026-07-30 · series begins 2022-03-29. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)58.1% |
| Ann. volatility (3Y)53.8% |
| Sharpe (1Y)1.95 |
| Sharpe (3Y)0.34 |
| Max drawdown (1Y)−17.1% |
| Max drawdown (3Y)−59.6% |
| Beta (3Y vs SPY)1.23 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| TPG GP A, LLC | 140.0M | $892M | 35.92% | −12.9% |
| FMR LLC | 58.7M | $374M | 15.06% | +25.3% |
| SUMMIT PARTNERS L P | 29.2M | $186M | 7.49% | −12.9% |
| BlackRock, Inc. | 18.1M | $116M | 4.65% | −5.0% |
| DIMENSIONAL FUND ADVISORS LP | 10.4M | $66M | 2.66% | +16.4% |
| JENNISON ASSOCIATES LLC | 10.2M | $65M | 2.62% | +38.5% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 9.7M | $62M | 2.48% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.9M | $50M | 2.03% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | — | — | $403.5M | +21.2% |
| 2025-12-31 | 2026-02-25 | — | — | $382.2M | +17.4% |
| 2025-09-30 | 2025-11-06 | — | — | $363.8M | +16.3% |
| 2025-06-30 | 2025-08-07 | — | — | $345.3M | +10.6% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
| Total debt / EBITDA4.26× |
| Sales growth 3Y18.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
